Fields of interest:
Ion channel screening, glp, hERG,herg channel, potassium channel, HEK,
CHO, CRO, S7A S7B, QT prolongation, cardiac action potential.
QT prolongation, pharmacology, safety pharmacology, herg screening,
Swissmedic, in vivo, in vitro, preclinical safety assessment.
patch-clamp, IKr, cisapride, terfenadine, astemizole, grepafloxacin, QT
interval, cardiac arrhythmias, FDA, myocytes, herg liability.
|